Conn Vicki S, Ruppar Todd M, Chan Keith C, Dunbar-Jacob Jacqueline, Pepper Ginette A, De Geest Sabina
University of Missouri , Columbia, MO , USA.
Curr Med Res Opin. 2015 Jan;31(1):145-60. doi: 10.1185/03007995.2014.978939. Epub 2014 Nov 4.
Inadequate medication adherence is a widespread problem that contributes to increased chronic disease complications and health care expenditures. Packaging interventions using pill boxes and blister packs have been widely recommended to address the medication adherence issue. This meta-analysis review determined the overall effect of packaging interventions on medication adherence and health outcomes. In addition, we tested whether effects vary depending on intervention, sample, and design characteristics.
Extensive literature search strategies included examination of 13 computerized databases and 19 research registries, hand searches of 57 journals, and author and ancestry searches. Eligible studies included either pill boxes or blister packaging interventions to increase medication adherence. Primary study characteristics and outcomes were reliably coded. Random-effects analyses were used to calculate overall effect sizes and conduct moderator analyses.
Data were synthesized across 22,858 subjects from 52 reports. The overall mean weighted standardized difference effect size for two-group comparisons was 0.593 (favoring treatment over control), which is consistent with the mean of 71% adherence for treatment subjects compared to 63% among control subjects. We found using moderator analyses that interventions were most effective when they used blister packs and were delivered in pharmacies, while interventions were less effective when studies included older subjects and those with cognitive impairment. Methodological moderator analyses revealed significantly larger effect sizes in studies reporting continuous data outcomes instead of dichotomous results and in studies using pharmacy refill medication adherence measures compared with studies with self-report measures.
Overall, meta-analysis findings support the use of packaging interventions to effectively increase medication adherence. Limitations of the study include the exclusion of packaging interventions other than pill boxes and blister packs, evidence of publication bias, and primary study sparse reporting of health outcomes and potentially interesting moderating variables such as the number of prescribed medications.
药物依从性不足是一个普遍存在的问题,会导致慢性病并发症增加和医疗保健支出上升。使用药盒和泡罩包装的包装干预措施已被广泛推荐用于解决药物依从性问题。本荟萃分析综述确定了包装干预对药物依从性和健康结果的总体影响。此外,我们还测试了效果是否因干预措施、样本和设计特征而异。
广泛的文献检索策略包括检查13个计算机化数据库和19个研究登记处、手工检索57种期刊以及作者检索和追溯检索。符合条件的研究包括使用药盒或泡罩包装干预措施来提高药物依从性。对主要研究特征和结果进行了可靠编码。采用随机效应分析来计算总体效应量并进行调节分析。
对来自52份报告的22,858名受试者的数据进行了综合分析。两组比较的总体平均加权标准化差异效应量为0.593(治疗组优于对照组),这与治疗组71%的依从性均值一致,而对照组为63%。我们通过调节分析发现,当干预措施使用泡罩包装并在药房提供时最为有效,而当研究纳入老年受试者和认知障碍患者时,干预措施效果较差。方法学调节分析显示,与采用自我报告测量的研究相比,报告连续数据结果而非二分结果的研究以及使用药房再填充药物依从性测量的研究,其效应量显著更大。
总体而言,荟萃分析结果支持使用包装干预措施来有效提高药物依从性。该研究的局限性包括排除了药盒和泡罩包装以外的包装干预措施、存在发表偏倚的证据,以及主要研究对健康结果和潜在有趣的调节变量(如处方药数量)的报告较少。